Rekah Pharmaceutical Industry Ltd. (TLV:REKA)
1,150.00
-45.00 (-3.77%)
Apr 20, 2026, 5:29 PM IDT
TLV:REKA Market Cap
TLV:REKA has a market cap or net worth of 131.27 million as of April 20, 2026. Its market cap has decreased by -16.91% in one year.
Market Cap
131.27M
Enterprise Value
259.33M
Revenue
300.99M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,150.00
Market Cap Chart
Since April 5, 2005, TLV:REKA's market cap has increased from 107.92M to 131.27M, an increase of 21.64%. That is a compound annual growth rate of 0.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 131.27M | 5.12% |
| Dec 31, 2025 | 124.88M | -17.43% |
| Dec 31, 2024 | 151.24M | -10.35% |
| Dec 31, 2023 | 168.71M | -3.96% |
| Dec 29, 2022 | 175.67M | -33.89% |
| Dec 30, 2021 | 265.73M | -13.13% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 111.99B |
| Danel (Adir Yeoshua) | 2.83B |
| Amal Holdings A.D. | 2.38B |
| BrainsWay | 1.86B |
| Epitomee Medical | 266.15M |
| Geffen Residence & Renewal | 259.73M |
| Golden House | 168.35M |
| InterCure | 125.93M |